Reviewer acknowledgment 2015.

PubWeight™: 0.75‹?›

🔗 View Article (PMID 26271076)

Published in CA Cancer J Clin on August 13, 2015

Authors

Otis W Brawley, Ted Gansler

Articles by these authors

Cancer treatment and survivorship statistics, 2012. CA Cancer J Clin (2012) 14.47

Effect of dutasteride on the risk of prostate cancer. N Engl J Med (2010) 12.78

Benefits and harms of CT screening for lung cancer: a systematic review. JAMA (2012) 8.71

Are racial and ethnic minorities less willing to participate in health research? PLoS Med (2005) 7.88

Nutrition and physical activity guidelines for cancer survivors. CA Cancer J Clin (2012) 4.77

Cancer screening in the United States, 2010: a review of current American Cancer Society guidelines and issues in cancer screening. CA Cancer J Clin (2010) 4.76

American Cancer Society Guidelines on Nutrition and Physical Activity for cancer prevention: reducing the risk of cancer with healthy food choices and physical activity. CA Cancer J Clin (2006) 4.69

American Cancer Society Guidelines on nutrition and physical activity for cancer prevention: reducing the risk of cancer with healthy food choices and physical activity. CA Cancer J Clin (2012) 4.32

Survival of blacks and whites after a cancer diagnosis. JAMA (2002) 4.27

Nutrition and physical activity during and after cancer treatment: an American Cancer Society guide for informed choices. CA Cancer J Clin (2006) 3.67

Cancer screening in the United States, 2009: a review of current American Cancer Society guidelines and issues in cancer screening. CA Cancer J Clin (2009) 3.25

Estrogen receptor breast cancer phenotypes in the Surveillance, Epidemiology, and End Results database. Breast Cancer Res Treat (2002) 3.19

American Cancer Society lung cancer screening guidelines. CA Cancer J Clin (2013) 3.16

Race and triple negative threats to breast cancer survival: a population-based study in Atlanta, GA. Breast Cancer Res Treat (2008) 2.97

Preventing cancer, cardiovascular disease, and diabetes: a common agenda for the American Cancer Society, the American Diabetes Association, and the American Heart Association. Circulation (2004) 2.91

Cancer screening in the United States, 2011: A review of current American Cancer Society guidelines and issues in cancer screening. CA Cancer J Clin (2011) 2.76

American society of clinical oncology policy statement: disparities in cancer care. J Clin Oncol (2009) 2.12

Low-dose spiral CT screening and evaluation of the solitary pulmonary nodule. Oncology (Williston Park) (2014) 2.06

Cancer screening in the United States, 2015: a review of current American cancer society guidelines and current issues in cancer screening. CA Cancer J Clin (2015) 1.97

Cancer screening in the United States, 2014: a review of current American Cancer Society guidelines and current issues in cancer screening. CA Cancer J Clin (2014) 1.95

The worldwide epidemiology of prostate cancer: perspectives from autopsy studies. Can J Urol (2008) 1.93

American Cancer Society guidelines on nutrition and physical activity for cancer prevention: Reducing the risk of cancer with healthy food choices and physical activity. CA Cancer J Clin (2002) 1.88

Cancer screening in the United States, 2013: a review of current American Cancer Society guidelines, current issues in cancer screening, and new guidance on cervical cancer screening and lung cancer screening. CA Cancer J Clin (2013) 1.75

Palliative care and the quality of life. J Clin Oncol (2011) 1.75

The effect of dutasteride on the usefulness of prostate specific antigen for the diagnosis of high grade and clinically relevant prostate cancer in men with a previous negative biopsy: results from the REDUCE study. J Urol (2010) 1.73

Adult weight gain and histopathologic characteristics of breast cancer among postmenopausal women. Cancer (2006) 1.55

Disaggregating the effects of race and poverty on breast cancer outcomes. J Natl Cancer Inst (2002) 1.44

High prevalence of triple-negative tumors in an urban cancer center. Cancer (2008) 1.43

Effects of untreated syphilis in the negro male, 1932 to 1972: a closure comes to the Tuskegee study, 2004. Urology (2005) 1.42

Racial differences in the presentation and outcomes of diffuse large B-cell lymphoma in the United States. Cancer (2010) 1.38

Effects of an outreach and internal navigation program on breast cancer diagnosis in an urban cancer center with a large African-American population. Cancer (2008) 1.36

Inflammation and cancer: an epidemiological perspective. Novartis Found Symp (2004) 1.34

Body mass and endometrial cancer risk by hormone replacement therapy and cancer subtype. Cancer Epidemiol Biomarkers Prev (2008) 1.30

Age and grade trends in prostate cancer (1974-2003): a Surveillance, Epidemiology, and End Results Registry analysis. Am J Clin Oncol (2008) 1.28

Extensive inguinal lymphadenectomy improves overall 5-year survival in penile cancer patients: results from the Surveillance, Epidemiology, and End Results program. Cancer (2010) 1.28

Preventing cancer, cardiovascular disease, and diabetes: a common agenda for the American Cancer Society, the American Diabetes Association, and the American Heart Association. Stroke (2004) 1.17

Disparities in the early adoption of chemoimmunotherapy for diffuse large B-cell lymphoma in the United States. Cancer Epidemiol Biomarkers Prev (2012) 1.14

Racial disparities in colorectal cancer. Curr Probl Cancer (2007) 1.11

From the guest editors: introduction for the impact of health care reform on cancer patients. Cancer J (2010) 1.08

Colorectal carcinoma in black and white race. Cancer Metastasis Rev (2003) 1.07

Prostate cancer: current evidence weighs against population screening. CA Cancer J Clin (2009) 1.05

Prostate cancer in black and white Americans. Cancer Metastasis Rev (2003) 1.05

Myeloma and race: a review of the literature. Cancer Metastasis Rev (2003) 1.00

The globalization of tobacco use: 21 challenges for the 21st century. CA Cancer J Clin (2010) 1.00

Disparities in medical care among commercially insured patients with newly diagnosed breast cancer: opportunities for intervention. Cancer (2010) 0.99

Introducing the 2010 American Cancer Society prostate cancer screening guideline. CA Cancer J Clin (2010) 0.99

Risk-based mammography screening: an effort to maximize the benefits and minimize the harms. Ann Intern Med (2012) 0.98

The study of accrual to clinical trials: can we learn from studying who enters our studies? J Clin Oncol (2004) 0.97

Is race really a negative prognostic factor for cancer? J Natl Cancer Inst (2009) 0.97

Racial disparities in lung cancer. Curr Probl Cancer (2007) 0.96

NIH consensus development statement on hydroxyurea treatment for sickle cell disease. NIH Consens State Sci Statements (2008) 0.95

Examining racial differences in diffuse large B-cell lymphoma presentation and survival. Leuk Lymphoma (2013) 0.95

Prevalence and sociodemographic correlates of beliefs regarding cancer risks. Cancer (2007) 0.94

Advancing survivorship care through the National Cancer Survivorship Resource Center: developing American Cancer Society guidelines for primary care providers. CA Cancer J Clin (2013) 0.93

A black-white comparison of the quality of stage-specific colon cancer treatment. Cancer (2010) 0.93

A prospective study of fruits, vegetables, and risk of endometrial cancer. Am J Epidemiol (2007) 0.93

Cancer caregiving predicts physical impairments: roles of earlier caregiving stress and being a spousal caregiver. Cancer (2014) 0.92

Characteristics and treatment modalities for African American women diagnosed with stage III breast cancer. Cancer (2009) 0.90

Avoidable cancer deaths globally. CA Cancer J Clin (2011) 0.90

Obesity-driven inflammation and cancer risk: role of myeloid derived suppressor cells and alternately activated macrophages. Am J Cancer Res (2013) 0.89

Some perspective on black-white cancer statistics. CA Cancer J Clin (2002) 0.89

Taking action to ease suffering: advancing cancer pain control as a health care priority. CA Cancer J Clin (2009) 0.89

Racial differences in the incidence and outcomes for patients with hematological malignancies. Curr Probl Cancer (2007) 0.88

Informed consent for prostate-specific antigen-based screening. Urology (2003) 0.84

A research agenda for radiation oncology: results of the radiation oncology institute's comprehensive research needs assessment. Int J Radiat Oncol Biol Phys (2012) 0.84

Lung cancer and race: equal treatment yields equal outcome among equal patients, but there is no equal treatment. J Clin Oncol (2005) 0.82

Health care policy and cancer survivorship. Cancer (2013) 0.82

CDC Grand Rounds: the future of cancer screening. MMWR Morb Mortal Wkly Rep (2015) 0.82

Prostate cancer screening; is this a teachable moment? J Natl Cancer Inst (2009) 0.81

Peak window of suicides occurs within the first month of diagnosis: implications for clinical oncology. Psychooncology (2011) 0.81

The role of psychological functioning in the use of complementary and alternative methods among disease-free colorectal cancer survivors: a report from the American Cancer Society's studies of cancer survivors. Cancer (2009) 0.81

The National Breast and Cervical Cancer Early Detection Program: toward a system of cancer screening in the United States. Cancer (2014) 0.80

From the editors. CA Cancer J Clin (2010) 0.77

The potential for prostate cancer chemoprevention. Rev Urol (2002) 0.77

"Lumping" vs "splitting" in oncologic pathology: association with cancer center type and case volume. J Registry Manag (2012) 0.76

Cancer survivors' spiritual well-being and use of complementary methods: a report from the American Cancer Society's Studies of Cancer Survivors. J Relig Health (2011) 0.75

Phase III prostate cancer chemoprevention trials. Recent Results Cancer Res (2014) 0.75

Oophorectomy in carriers of BRCA mutations. N Engl J Med (2002) 0.75

Navigating the health service network: helping cancer survivors find what they need. CA Cancer J Clin (2002) 0.75

Evaluation of the American Cancer Society's breast cancer-related documents by cancer survivors. J Cancer Educ (2003) 0.75

Trends in Diagnosis of Gleason Score 2 Through 4 Prostate Cancer in the National Cancer Database, 1990-2013. Arch Pathol Lab Med (2017) 0.75

Chemoprevention in prostate cancer. Curr Probl Cancer (2004) 0.75

Information over exaggeration. US News World Rep (2009) 0.75

New ACS chief medical officer. Interview by Carrie Printz. Cancer (2008) 0.75

Curbing tobacco's toll starts with the professionals: World No Tobacco Day. Lancet (2005) 0.75

The argument for breast cancer screening. Clin Adv Hematol Oncol (2014) 0.75

Axillary lymphatic disruption does not increase risk of breast carcinoma. Breast J (2009) 0.75

A brief history of the American Cancer Society Extramural Research Program. CA Cancer J Clin (2012) 0.75

Most Gleason 8 Biopsies are Downgraded on Prostatectomy: Does 4+4=7? J Urol (2017) 0.75

Aspiration cytology of the conjunctival surface. Acta Cytol (2003) 0.75